Relx (NYSE:RELX) Downgraded to “Hold” Rating by StockNews.com

StockNews.com cut shares of Relx (NYSE:RELX) from a buy rating to a hold rating in a research report sent to investors on Saturday morning.

Separately, Redburn Atlantic assumed coverage on Relx in a research note on Wednesday, January 8th. They set a “buy” rating on the stock.

Relx Trading Down 0.2 %

RELX opened at $49.22 on Friday. The stock has a market cap of $91.47 billion, a price-to-earnings ratio of 26.46, a P/E/G ratio of 2.73 and a beta of 0.90. The stock’s 50 day moving average price is $48.18 and its 200-day moving average price is $47.38. Relx has a one year low of $40.25 and a one year high of $51.99. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52.

Relx Increases Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be paid a $0.5586 dividend. The ex-dividend date of this dividend is Friday, May 9th. This represents a yield of 1.6%. This is a boost from Relx’s previous semi-annual dividend of $0.23. Relx’s dividend payout ratio is 59.68%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of RELX. CENTRAL TRUST Co grew its stake in Relx by 1,290.2% in the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after purchasing an additional 529 shares in the last quarter. Versant Capital Management Inc bought a new position in Relx in the fourth quarter worth approximately $31,000. Transce3nd LLC bought a new position in Relx in the fourth quarter worth approximately $40,000. Sierra Ocean LLC bought a new position in Relx in the fourth quarter worth approximately $43,000. Finally, Brown Brothers Harriman & Co. grew its stake in Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company’s stock worth $44,000 after purchasing an additional 662 shares in the last quarter. Institutional investors own 15.02% of the company’s stock.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.